What Researchers Did
The authors wrote up the case of an extremely low birth weight preterm infant who developed purpura fulminans, a rare and fatal skin and soft tissue condition, and who was treated with hyperbaric oxygen therapy (HBOT).
What They Found
This case report describes an extremely low birth weight preterm infant with purpura fulminans that started in the fingers of the right hand, and the abstract reports protein S deficiency plus homozygous MTHFR (A1298C) and Factor V Leiden (R506Q) mutations. The infant did not respond to fresh frozen plasma or unfractionated heparin. The authors then describe HBOT as a curative treatment and note it had not previously been used for this purpose in extremely low birth weight preterm infants. The abstract gives no outcome data, no HBOT pressure or session count, and no measured results.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a report of one infant with no comparison group, and the abstract provides no outcome measures, HBOT protocol details or follow-up, so it cannot show that HBOT caused any improvement.